APOA2 Gene Hypercholesterolemia familial modifier of Genetic Test
At DNA Labs UAE, we offer the APOA2 Gene Hypercholesterolemia familial modifier of Genetic Test at a price of 4400.0 AED. This test is used to diagnose and manage APOA2 Gene Hypercholesterolemia, a genetic condition characterized by high levels of cholesterol in the blood.
Test Details
APOA2 Gene Hypercholesterolemia is caused by mutations in the APOA2 gene, which affects the production of apolipoprotein A-II, a protein involved in lipid metabolism, including cholesterol. Mutations in the APOA2 gene can lead to elevated levels of LDL cholesterol, also known as “bad” cholesterol.
Our APOA2 Gene Hypercholesterolemia test utilizes NGS (Next-Generation Sequencing) technology, allowing us to analyze multiple genes simultaneously to identify genetic variations or mutations associated with this condition. By identifying specific genetic mutations, we can provide valuable information for diagnosis, management, and personalized treatment plans.
Pre Test Information
Before undergoing the APOA2 Gene Hypercholesterolemia test, it is recommended to have a clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected by Hypercholesterolemia. This will help us understand the familial pattern and severity of the condition.
Test Components and Sample Condition
The APOA2 Gene Hypercholesterolemia test requires a blood or extracted DNA sample. Alternatively, one drop of blood can be collected on an FTA Card. These samples will be used to analyze the DNA for mutations in the APOA2 gene.
Report Delivery and Test Type
After sample collection, the report will be delivered within 3 to 4 weeks. The APOA2 Gene Hypercholesterolemia test falls under the category of Metabolic Disorders in our Genetics department.
Doctor and Test Department
This test can be ordered by a General Physician and is conducted in our Genetics department.
Overall, the APOA2 Gene Hypercholesterolemia familial modifier of Genetic Test is an essential tool for diagnosing and managing high cholesterol levels. It can provide valuable information about the risk of cardiovascular diseases and guide personalized treatment plans. By understanding the genetic mutations associated with APOA2 Gene Hypercholesterolemia, individuals and healthcare providers can make informed decisions to improve their health.
| Test Name | APOA2 Gene Hypercholesterolemia familial modifier of Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for APOA2 Gene Hypercholesterolemia, familial, modifier of NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercholesterolemia, familial, modifier of |
| Test Details |
APOA2 Gene Hypercholesterolemia is a genetic condition characterized by high levels of cholesterol in the blood. It is caused by mutations in the APOA2 gene, which provides instructions for making a protein called apolipoprotein A-II. Apolipoprotein A-II plays a role in the metabolism of lipids, including cholesterol. Mutations in the APOA2 gene can lead to abnormal functioning of this protein, resulting in elevated levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol. NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations associated with a particular condition. In the case of APOA2 Gene Hypercholesterolemia, NGS Genetic Testing can be used to identify mutations in the APOA2 gene that may be contributing to the high cholesterol levels. Identifying the specific genetic mutations associated with APOA2 Gene Hypercholesterolemia can help in the diagnosis and management of the condition. It can also provide information about the risk of developing cardiovascular diseases and guide personalized treatment plans, such as lifestyle modifications and medication choices. It is important to note that APOA2 Gene Hypercholesterolemia is a modifier of familial hypercholesterolemia, which means that it can influence the severity or progression of the condition in individuals who already have familial hypercholesterolemia due to mutations in other genes, such as LDL receptor gene (LDLR) or apolipoprotein B gene (APOB). NGS Genetic Testing for APOA2 Gene Hypercholesterolemia can be performed by collecting a blood or saliva sample and analyzing the DNA for mutations in the APOA2 gene. The test results can provide valuable information for individuals and their healthcare providers to make informed decisions about managing their cholesterol levels and reducing the risk of cardiovascular diseases. |
